ACUCORT AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.52 SEK | -3.70% |
|
-3.70% | +25.30% |
| 04-26 | AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-16 | AcuCort AB Provides Update on Phase IV Study ZEQ001 | CI |
| Sales 2022 | 5.02 54.77 401.13 | Sales 2023 | 6.59 71.88 526.43 | Capitalization | 12.98M 142M 1.04B |
|---|---|---|---|---|---|
| Net income 2022 | -14M -153M -1.12B | Net income 2023 | -13M -142M -1.04B | EV / Sales 2022 | 8,567,999 x |
| Net cash position 2022 | 17.18M 187M 1.37B | Net cash position 2023 | 19.24M 210M 1.54B | EV / Sales 2023 | -949,961 x |
| P/E ratio 2022 |
-4.1
x | P/E ratio 2023 |
-0.94
x | Employees | 3 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 81.96% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -3.70% | ||
| 1 week | -3.70% | ||
| Current month | -13.33% | ||
| 1 month | -13.33% | ||
| 3 months | +46.89% | ||
| 6 months | +21.50% | ||
| Current year | +25.30% |
1 week
0.48
0.61
1 month
0.440.68
Current year
0.340.70
1 year
0.331.60
3 years
0.335.42
5 years
0.337.90
10 years
0.339.50
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 08/08/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 07/02/17 | |
Göran Tornling
BRD | Director/Board Member | 77 | 31/12/20 |
| Director/Board Member | 68 | 31/12/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 0.52 | -3.70% | 331,771 |
| 29/04/24 | 0.54 | -3.57% | 845,507 |
| 26/04/24 | 0.56 | -6.67% | 1,644,357 |
| 25/04/24 | 0.6 | +5.26% | 1,561,091 |
| 24/04/24 | 0.57 | +3.64% | 1,149,640 |
End-of-day quote NORDIC GROWTH MARKET, April 29, 2024
More quotes
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Sector
Drug Retailers
Calendar
22/08/2024
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +25.30% | 5.65M | |
| -33.59% | 14.96B | |
| -24.17% | 11.07B | |
| +9.74% | 6.13B | |
| -10.91% | 5.98B | |
| +0.88% | 4.76B | |
| +53.60% | 4.36B | |
| -10.49% | 3.73B | |
| -12.53% | 3.43B | |
| -7.34% | 3.02B |
- Stock Market
- Equities
- ACUC Stock
